Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 30, 2013

View Archived Issues

The identification of an accessory protein that plays a role in mammalian obesity

Astex Pharmaceuticals reports topline results from phase II SGI-110 trial

New monoclonal antibodies disclosed as modulators of CD324

The role of B7-H6/NKp30 axis in the pathogenesis of primary Sjogren's syndrome

NAPOLI-1 liposomal irinotecan trial reaches enrollment goal

Clovis begins dosing with new formulation of CO-1686

Daewoong presents bioequivalence data for rosuvastatin/olmesartan fixed-dose formulation

FDA accepts ibrutinib NDA filing for review

Epirus Biopharmaceuticals reports phase III data on biosimilar infliximab product

Isis Pharmaceuticals begins phase II diabetes study

Constellation Pharmaceuticals discloses novel EZH2 inhibitors

Researchers at Orbsen Therapeutics design novel stromal stem cells

Dezima Pharma begins phase IIb TULIP trial for DEZ-001

Idera Pharmaceuticals and NCI enter M-CRADA agreement

AbbVie initiates second pivotal study of elagolix for endometriosis

Improved control of recurrent UTIs with quorum sensing inhibitor LED-209

FDA issues tolvaptan CRL for kidney disease

Stivarga approved in E.U. for metastatic colorectal cancer

OPKO Health completes acquisition of Prolor Biotech

Novel HDAC inhibitor shows potent antiproliferative activity in vivo

Researchers disclose new agents for the diagnosis of cancer and gastrointestinal disorders

French team synthesizes new antibacterial agents

Scientists at Daiichi Sankyo patent new sodium channel blockers

Zealand and Lilly to collaborate on first-in-class peptide therapeutics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...